Allstate (NYSE:ALL) PT Lowered to $200.00

Allstate (NYSE:ALL) had its price objective lowered by research analysts at Morgan Stanley from $205.00 to $200.00 in a report released on Wednesday, Benzinga reports. The brokerage presently has an “overweight” rating on the insurance provider’s stock. Morgan Stanley’s price target would suggest a potential upside of 25.88% from the company’s previous close.

ALL has been the topic of several other reports. Wells Fargo & Company lifted their price target on Allstate from $146.00 to $153.00 and gave the stock an “underweight” rating in a research report on Friday, May 10th. Keefe, Bruyette & Woods reaffirmed an “outperform” rating and issued a $194.00 price target on shares of Allstate in a research report on Friday, July 5th. JPMorgan Chase & Co. lifted their price target on Allstate from $185.00 to $193.00 and gave the stock an “overweight” rating in a research report on Thursday, May 2nd. Roth Mkm lifted their price target on Allstate from $175.00 to $200.00 and gave the stock a “buy” rating in a research report on Monday, April 8th. Finally, HSBC raised Allstate from a “hold” rating to a “buy” rating and lifted their price objective for the stock from $158.00 to $190.00 in a report on Thursday, March 28th. One analyst has rated the stock with a sell rating, three have assigned a hold rating, twelve have assigned a buy rating and one has given a strong buy rating to the company. According to MarketBeat, Allstate presently has an average rating of “Moderate Buy” and a consensus price target of $175.47.

Allstate Stock Performance

Shares of ALL stock traded up $0.16 during trading on Wednesday, reaching $158.88. The company had a trading volume of 476,667 shares, compared to its average volume of 1,569,984. The firm’s 50 day simple moving average is $164.10 and its two-hundred day simple moving average is $161.25. The company has a debt-to-equity ratio of 0.48, a current ratio of 0.36 and a quick ratio of 0.36. Allstate has a one year low of $100.57 and a one year high of $177.37. The company has a market capitalization of $41.93 billion, a PE ratio of 35.09, a PEG ratio of 1.88 and a beta of 0.48.

Allstate (NYSE:ALL) last issued its quarterly earnings results on Thursday, May 2nd. The insurance provider reported $5.13 EPS for the quarter, topping the consensus estimate of $4.11 by $1.02. The company had revenue of $15.26 billion for the quarter, compared to the consensus estimate of $12.76 billion. Allstate had a return on equity of 14.44% and a net margin of 2.31%. The company’s revenue for the quarter was up 10.7% on a year-over-year basis. During the same period in the previous year, the business posted ($1.30) EPS. Sell-side analysts forecast that Allstate will post 12.15 earnings per share for the current year.

Institutional Trading of Allstate

Several institutional investors have recently bought and sold shares of ALL. Vanguard Group Inc. boosted its stake in Allstate by 11.5% in the 3rd quarter. Vanguard Group Inc. now owns 32,270,589 shares of the insurance provider’s stock valued at $3,595,266,000 after buying an additional 3,322,673 shares in the last quarter. Norges Bank bought a new position in Allstate in the 4th quarter valued at $212,771,000. Palestra Capital Management LLC bought a new position in Allstate in the 4th quarter valued at $83,561,000. Balyasny Asset Management L.P. bought a new position in Allstate in the 4th quarter valued at $81,571,000. Finally, Artemis Investment Management LLP bought a new position in Allstate in the 1st quarter valued at $95,764,000. Institutional investors and hedge funds own 76.47% of the company’s stock.

Allstate Company Profile

The Allstate Corporation, together with its subsidiaries, provides property and casualty, and other insurance products in the United States and Canada. It operates in five segments: Allstate Protection; Protection Services; Allstate Health and Benefits; Run-off Property-Liability; and Corporate and Other segments.